Literature DB >> 25428396

Association of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis.

Tao Zeng1, Yue-Sheng Long, Fu-Li Min, Wei-Ping Liao, Yi-Wu Shi.   

Abstract

BACKGROUND: Despite several studies investigating the association between the human leukocyte antigen HLA-B*1502 allele and lamotrigine-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Han Chinese subjects, the relationship remains unclear.
OBJECTIVES: We performed a systematic review and meta-analysis to ascertain the association between the HLA-B*1502 allele and lamotrigine-induced SJS and TEN in Han Chinese populations.
METHODS: We searched the biomedical literature archived in the MEDLINE, Cochrane Library, EMBASE, Chinese Biomedical, Chinese National Knowledge Infrastructure, and China Science and Technology Journal databases. Only studies investigating the association between HLA-B*1502 and lamotrigine-induced SJS/TEN were included. We then performed a meta-analysis of the data in these studies.
RESULTS: Four studies including a total of 12 patients with SJS/TEN and 128 lamotrigine-tolerant control subjects were identified. The HLA-B*1502 allele was present in 33.3% (four of 12) of lamotrigine-induced SJS/TEN cases but in only 9.4% (12 of 128) of lamotrigine-tolerant controls. The occurrence of SJS/TEN was thus associated with the presence of the HLA-B*1502 allele (odds ratio: 4.98, 95% confidence interval 1.43-17.28; P < 0.05).
CONCLUSIONS: We found a statistical association between HLA-B*1502 and lamotrigine-induced SJS/TEN in Han Chinese subjects. Future studies with larger sample sizes are suggested to verify the results.
© 2014 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25428396     DOI: 10.1111/ijd.12570

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

1.  Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines.

Authors:  Lisanne E N Manson; Jesse J Swen; Henk-Jan Guchelaar
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

Review 2.  Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.

Authors:  Kalliopi Gerogianni; Aspasia Tsezou; Konstantinos Dimas
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.476

Review 3.  Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions.

Authors:  Ruwen Böhm; Ingolf Cascorbi
Journal:  Front Pharmacol       Date:  2016-10-21       Impact factor: 5.810

4.  Cutaneous Adverse Drug Reactions to Lamotrigine and Human Leukocyte Antigen Typing in North Indian Patients: A Case Series.

Authors:  Shivani Srivastava; Bhargavi Ramanujam; Kavish Ihtisham; Manjari Tripathi
Journal:  Ann Indian Acad Neurol       Date:  2017 Oct-Dec       Impact factor: 1.383

5.  HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions.

Authors:  Seyed Hasan Tonekaboni; Narjes Jafari; Mahboubeh Mansouri; Sayena Jabbehdari; Rahil Eftekhari; Zahra Chavoshzadeh; Fatemeh Abdollah Gorji; Mehrnaz Mesdaghi
Journal:  Iran J Child Neurol       Date:  2017

6.  Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials.

Authors:  Romi Bloom; Kyle T Amber
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

Review 7.  An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.

Authors:  Chun-Bing Chen; Riichiro Abe; Ren-You Pan; Chuang-Wei Wang; Shuen-Iu Hung; Yi-Giien Tsai; Wen-Hung Chung
Journal:  J Immunol Res       Date:  2018-02-13       Impact factor: 4.818

Review 8.  Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions.

Authors:  Ali Fadhel Ahmed; Chonlaphat Sukasem; Majeed Arsheed Sabbah; Nur Fadhlina Musa; Dzul Azri Mohamed Noor; Nur Aizati Athirah Daud
Journal:  J Pers Med       Date:  2021-05-07

9.  HLA-A∗24:02 associated with lamotrigine-induced cutaneous adverse drug reactions: A systematic review and meta-analysis.

Authors:  Wanshu Li; Jie Wang; Hangjuan Lin; Gang Shen
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.